Integer Cash Flow Statement
NYSE: ITGRHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Integer free cash flow
In fiscal 2025, Integer generated $196.1 million of operating cash flow and spent $91.0 million on capital expenditures. That left free cash flow of $105.1 million, a free-cash-flow margin of 5.7% of revenue. Free cash flow was up 5.3% from the prior year's $99.8 million.
Integer returned $50.0 million to shareholders through share repurchases, equal to 48% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Integer cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-28 | FY 20172017-12-29 | FY 20162016-12-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 102.81M | 119.90M | 90.65M | 66.38M | 96.81M | 77.26M | 96.34M | 167.96M | 66.68M | 5.96M |
| Net Income growth (YoY) | -14.25% | +32.26% | +36.57% | -31.43% | +25.30% | -19.80% | -42.64% | +151.90% | +1018.59% | — |
| Depreciation & Amortization | 130.67M | 111.03M | 98.84M | 91.99M | 81.37M | 79.32M | 77.89M | 88.99M | 102.80M | 90.52M |
| Stock-Based Compensation | 23.22M | 24.77M | 23.28M | 21.02M | 16.18M | 9.16M | 9.29M | 10.47M | 14.68M | 8.41M |
| Change in Working Capital | -108.29M | -36.99M | -31.16M | -80.83M | -18.71M | 35.95M | -10.40M | -10.13M | -10.87M | 1.09M |
| Operating Cash Flow | 196.15M | 205.21M | 180.21M | 116.38M | 156.67M | 181.34M | 165.36M | 167.30M | 149.36M | 105.53M |
| Capital Expenditures | -91.03M | -105.36M | -119.94M | -74.73M | -53.46M | -46.83M | -48.20M | -44.91M | -47.30M | -58.63M |
| Investing Cash Flow | -270.73M | -195.41M | -163.37M | -200.42M | -271.00M | -56.58M | -58.86M | 536.67M | -47.94M | -63.30M |
| Share Repurchases | -50.01M | 0 | 0 | — | — | — | — | — | — | — |
| Debt Issued | 977.50M | 0 | 486.25M | 0 | 818.25M | 0 | 0 | 5.00M | 50.00M | 57.00M |
| Debt Repaid | -667.71M | -6.00K | -415.94M | — | — | — | — | -705.47M | -178.56M | -46.00M |
| Financing Cash Flow | 43.56M | 13.32M | -18.01M | 92.48M | 81.99M | -88.58M | -117.93M | -725.08M | -111.67M | -72.15M |
| Net Change in Cash | -29.38M | 22.87M | -598.00K | 6.39M | -31.32M | 35.67M | -12.03M | -18.53M | -8.02M | -30.36M |
| Free Cash Flow | 105.12M | 99.85M | 60.27M | 41.65M | 103.20M | 134.51M | 117.16M | 122.39M | 102.06M | 46.90M |
This table shows 10 annual periods of Integer's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ITGR's reporting calendar. What is a cash flow statement?